Affinity DataKi: 2.60nMAssay Description:In vitro binding affinity against 5-HT1A receptor of rat hippocampus using [3H]-8-OH-DPATMore data for this Ligand-Target Pair
Affinity DataKi: 2.70nMAssay Description:In vitro binding affinity against 5-HT1A receptor of rat hippocampus using [3H]-8-OH-DPATMore data for this Ligand-Target Pair
Affinity DataKi: 4.20nMAssay Description:In vitro binding affinity against 5-HT1A receptor of rat hippocampus using [3H]-8-OH-DPATMore data for this Ligand-Target Pair
TargetAlpha-2A adrenergic receptor [16-465]/Alpha-2B adrenergic receptor/Alpha-2C adrenergic receptor(RAT)
Postech
Curated by ChEMBL
Postech
Curated by ChEMBL
Affinity DataKi: 11nMAssay Description:In vitro binding affinity against Alpha-2 adrenergic receptor of rat cerebral cortex using [3H]RX-821002More data for this Ligand-Target Pair
Affinity DataKi: 12nMAssay Description:In vitro binding affinity against 5-HT1A receptor of rat hippocampus using [3H]-8-OH-DPATMore data for this Ligand-Target Pair
TargetAlpha-2A adrenergic receptor [16-465]/Alpha-2B adrenergic receptor/Alpha-2C adrenergic receptor(RAT)
Postech
Curated by ChEMBL
Postech
Curated by ChEMBL
Affinity DataKi: 12nMAssay Description:In vitro binding affinity against Alpha-2 adrenergic receptor of rat cerebral cortex using [3H]RX-821002More data for this Ligand-Target Pair
Affinity DataKi: 15nMAssay Description:In vitro binding affinity against 5-HT1A receptor of rat hippocampus using [3H]-8-OH-DPATMore data for this Ligand-Target Pair
TargetAlpha-2A adrenergic receptor [16-465]/Alpha-2B adrenergic receptor/Alpha-2C adrenergic receptor(RAT)
Postech
Curated by ChEMBL
Postech
Curated by ChEMBL
Affinity DataKi: 16nMAssay Description:In vitro binding affinity against Alpha-2 adrenergic receptor of rat cerebral cortex using [3H]RX-821002More data for this Ligand-Target Pair
TargetAlpha-2A adrenergic receptor [16-465]/Alpha-2B adrenergic receptor/Alpha-2C adrenergic receptor(RAT)
Postech
Curated by ChEMBL
Postech
Curated by ChEMBL
Affinity DataKi: 24nMAssay Description:In vitro binding affinity against Alpha-2 adrenergic receptor of rat cerebral cortex using [3H]RX-821002More data for this Ligand-Target Pair
Affinity DataKi: 30nMAssay Description:In vitro binding affinity against 5-HT1A receptor of rat hippocampus using [3H]-8-OH-DPATMore data for this Ligand-Target Pair
Affinity DataKi: 31nMAssay Description:In vitro binding affinity against 5-HT1A receptor of rat hippocampus using [3H]-8-OH-DPATMore data for this Ligand-Target Pair
Affinity DataKi: 34nMAssay Description:In vitro binding affinity against 5-HT2A receptor of rat cerebrial cortex using [3H]-ketanserinMore data for this Ligand-Target Pair
TargetAlpha-2A adrenergic receptor [16-465]/Alpha-2B adrenergic receptor/Alpha-2C adrenergic receptor(RAT)
Postech
Curated by ChEMBL
Postech
Curated by ChEMBL
Affinity DataKi: 44nMAssay Description:In vitro binding affinity against Alpha-2 adrenergic receptor of rat cerebral cortex using [3H]RX-821002More data for this Ligand-Target Pair
Affinity DataKi: 46nMAssay Description:In vitro binding affinity against 5-HT2A receptor of rat cerebrial cortex using [3H]-ketanserinMore data for this Ligand-Target Pair
Affinity DataKi: 46nMAssay Description:In vitro binding affinity against 5-HT2A receptor of rat cerebrial cortex using [3H]-ketanserinMore data for this Ligand-Target Pair
TargetAlpha-2A adrenergic receptor [16-465]/Alpha-2B adrenergic receptor/Alpha-2C adrenergic receptor(RAT)
Postech
Curated by ChEMBL
Postech
Curated by ChEMBL
Affinity DataKi: 56nMAssay Description:In vitro binding affinity against Alpha-2 adrenergic receptor of rat cerebral cortex using [3H]RX-821002More data for this Ligand-Target Pair
Affinity DataKi: 77nMAssay Description:In vitro binding affinity against Dopamine receptor D2 of rat striatum using [3H]-racloprideMore data for this Ligand-Target Pair
Affinity DataKi: 184nMAssay Description:In vitro binding affinity against 5-HT2A receptor of rat cerebrial cortex using [3H]-ketanserinMore data for this Ligand-Target Pair
Affinity DataKi: 185nMAssay Description:In vitro binding affinity against Dopamine receptor D2 of rat striatum using [3H]-racloprideMore data for this Ligand-Target Pair
Affinity DataKi: 195nMAssay Description:In vitro binding affinity against Dopamine receptor D2 of rat striatum using [3H]-racloprideMore data for this Ligand-Target Pair
Affinity DataKi: 232nMAssay Description:In vitro binding affinity against 5-HT2A receptor of rat cerebrial cortex using [3H]-ketanserinMore data for this Ligand-Target Pair
Affinity DataKi: 263nMAssay Description:In vitro binding affinity against Dopamine receptor D2 of rat striatum using [3H]-racloprideMore data for this Ligand-Target Pair
Affinity DataKi: 320nMAssay Description:In vitro binding affinity against 5-HT2A receptor of rat cerebrial cortex using [3H]-ketanserinMore data for this Ligand-Target Pair
Affinity DataKi: 327nMAssay Description:In vitro binding affinity against Dopamine receptor D2 of rat striatum using [3H]-racloprideMore data for this Ligand-Target Pair
TargetAlpha-2A adrenergic receptor [16-465]/Alpha-2B adrenergic receptor/Alpha-2C adrenergic receptor(RAT)
Postech
Curated by ChEMBL
Postech
Curated by ChEMBL
Affinity DataKi: 334nMAssay Description:In vitro binding affinity against Alpha-2 adrenergic receptor of rat cerebral cortex using [3H]RX-821002More data for this Ligand-Target Pair
Affinity DataKi: 334nMAssay Description:In vitro binding affinity against Dopamine receptor D2 of rat striatum using [3H]-racloprideMore data for this Ligand-Target Pair
Affinity DataKi: >367nMAssay Description:In vitro binding affinity against 5-HT2A receptor of rat cerebrial cortex using [3H]-ketanserinMore data for this Ligand-Target Pair
Affinity DataKi: 783nMAssay Description:In vitro binding affinity against Dopamine receptor D2 of rat striatum using [3H]-racloprideMore data for this Ligand-Target Pair
Affinity DataKi: 1.57E+3nMAssay Description:In vitro binding affinity against Dopamine receptor D1 of rat striatum using [3H]-SCH-23,390More data for this Ligand-Target Pair
Affinity DataKi: 1.62E+3nMAssay Description:In vitro binding affinity against Dopamine receptor D1 of rat striatum using [3H]-SCH-23,390More data for this Ligand-Target Pair
Affinity DataKi: 1.95E+3nMAssay Description:In vitro binding affinity against Dopamine receptor D1 of rat striatum using [3H]-SCH-23,390More data for this Ligand-Target Pair
Affinity DataKi: 6.67E+3nMAssay Description:In vitro binding affinity against Dopamine receptor D1 of rat striatum using [3H]-SCH-23,390More data for this Ligand-Target Pair
Affinity DataKi: 1.25E+4nMAssay Description:In vitro binding affinity against Dopamine receptor D1 of rat striatum using [3H]-SCH-23,390More data for this Ligand-Target Pair
Affinity DataKi: 3.76E+4nMAssay Description:In vitro binding affinity against Dopamine receptor D1 of rat striatum using [3H]-SCH-23,390More data for this Ligand-Target Pair
Affinity DataKi: 8.81E+4nMAssay Description:In vitro binding affinity against Dopamine receptor D1 of rat striatum using [3H]-SCH-23,390More data for this Ligand-Target Pair
Affinity DataIC50: 1.30nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as inhibition of sodium-dependent [14C]methyl-alpha-D-glucopyranoside uptake after 45 minsMore data for this Ligand-Target Pair
Affinity DataIC50: 1.30nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as inhibition of sodium-dependent [14C]methyl-alpha-D-glucopyranoside uptake after 45 minsMore data for this Ligand-Target Pair
Affinity DataIC50: 1.40nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as inhibition of sodium-dependent [14C]methyl-alpha-D-glucopyranoside uptake after 45 minsMore data for this Ligand-Target Pair
Affinity DataIC50: 1.40nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as inhibition of sodium-dependent [14C]methyl-alpha-D-glucopyranoside uptake after 45 minsMore data for this Ligand-Target Pair
Affinity DataIC50: 1.60nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as inhibition of sodium-dependent [14C]methyl-alpha-D-glucopyranoside uptake after 45 minsMore data for this Ligand-Target Pair
Affinity DataIC50: 2.90nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as inhibition of sodium-dependent [14C]methyl-alpha-D-glucopyranoside uptake after 45 minsMore data for this Ligand-Target Pair
Affinity DataIC50: 3.20nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as inhibition of sodium-dependent [14C]methyl-alpha-D-glucopyranoside uptake after 45 minsMore data for this Ligand-Target Pair
Affinity DataIC50: 3.60nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as inhibition of sodium-dependent [14C]methyl-alpha-D-glucopyranoside uptake after 45 minsMore data for this Ligand-Target Pair
Affinity DataIC50: 4.80nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as inhibition of sodium-dependent [14C]methyl-alpha-D-glucopyranoside uptake after 45 minsMore data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Manros Therapeutics & Perha Pharmaceuticals
Curated by ChEMBL
Manros Therapeutics & Perha Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 7nMAssay Description:Inhibition of GST-fused human recombinant DYRK1A expressed in Escherichia coli using GRSRSRSRSRSR peptide as substrate incubated for 30 mins in prese...More data for this Ligand-Target Pair
Affinity DataIC50: 7.5nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as inhibition of sodium-dependent [14C]methyl-alpha-D-glucopyranoside uptake after 45 minsMore data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 2(Homo sapiens (Human))
Manros Therapeutics & Perha Pharmaceuticals
Curated by ChEMBL
Manros Therapeutics & Perha Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 8nMAssay Description:Inhibition of GST-fused human recombinant DYRK2 expressed in Escherichia coli using GRSRSRSRSRSR peptide as substrate incubated for 30 mins in presen...More data for this Ligand-Target Pair
Affinity DataIC50: 9.10nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as inhibition of sodium-dependent [14C]methyl-alpha-D-glucopyranoside uptake after 45 minsMore data for this Ligand-Target Pair
Affinity DataIC50: 9.60nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as inhibition of sodium-dependent [14C]methyl-alpha-D-glucopyranoside uptake after 45 minsMore data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 3(Homo sapiens (Human))
Manros Therapeutics & Perha Pharmaceuticals
Curated by ChEMBL
Manros Therapeutics & Perha Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 10nMAssay Description:Inhibition of GST-fused human recombinant DYRK3 expressed in Escherichia coli using GRSRSRSRSRSR peptide as substrate incubated for 30 mins in presen...More data for this Ligand-Target Pair